Nutriband Inc. to Showcase Innovations at Noble Conference
Nutriband Inc. is set to make a significant impact at the upcoming Noble Conference, which takes place at Florida Atlantic University. The event is scheduled for early December, where the company will highlight its advancements in transdermal pharmaceutical products.
Key Presentation Details
At the Noble Conference, Company President and Chairman Serguei Melnik will deliver a presentation focused on their pioneering AVERSA technology. This session is planned for 1:30 PM on December 4, where important insights regarding their lead product, an abuse-deterrent fentanyl patch, will be shared.
About AVERSA Technology
The AVERSA technology is noteworthy for its potential to revolutionize how transdermal patches are utilized in the pharmaceutical industry. By preventing abuse, misuse, and accidental exposure, this innovation aims to enhance the safety profile of potent medications.
Company Portfolio and Development Focus
Nutriband primarily specializes in developing a range of transdermal pharmaceutical products, with the abuse-deterrent fentanyl patch being the center of their ongoing research. This emphasizes their commitment to addressing the challenges posed by opioid use in medicine today, creating solutions aimed at reducing associated risks.
Engagement with Stakeholders
Following the conference, details of the presentation, including a live replay, will be available on various platforms, allowing stakeholders and the public to access the information shared during this important event.
Contact Information
For further inquiries, interested parties can reach out to RedChip Companies, Inc. or directly to Nutriband. Their contact details, including email and phone numbers, are provided for accessibility, ensuring that communication lines remain open for any questions or partnerships.
Frequently Asked Questions
What is the focus of Nutriband Inc.'s presentation at the conference?
Nutriband Inc.'s presentation will primarily focus on their AVERSA technology and its applications in development of abuse-deterrent fentanyl patches.
When will Nutriband's presentation take place?
The presentation is set for December 4 at 1:30 PM in Conference room 3.
How can the public access the presentation after the conference?
Details and a replay of the presentation will be shared on platforms such as Channelchek and YouTube following the conference.
What is the significance of AVERSA technology?
AVERSA technology is designed to prevent abuse, misuse, and accidental exposure to potent medications, enhancing patient safety in pharmaceutical applications.
What contact methods are available for Nutriband Inc.?
Nutriband can be contacted via their official email info@nutriband.com or by phone at 407-377-6695.
